Nebenwirkungen · NovoNorm
NovoNorm 0.5 mg tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-088431 · Präparat HOS-083643
Immune system disorders Allergic reactions* Very rare Metabolism and nutrition Hypoglycaemia Common disorders Hypoglycaemic coma and Not known hypoglycaemic unconsciousness Eye disorders Refraction disorder* Very rare Cardiac disorders Cardiovascular disease Rare Gastrointestinal disorders Abdominal pain, diarrhoea Common Vomiting, constipation Very rare Nausea Not known Hepatobiliary disorders Abnormal hepatic Very rare function, increased liver enzymes* Skin and subcutaneous tissue Hypersensitivity* Not known disorders * see section Description of selected adverse reactions below
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2017-09-28T02:00:00Z · SHA-256 21f3e9a965985080da26b53db087c3ea5427f5ec520967dcb4970774d891373a · Passage 0f1155934af33b3fbfd31433b68e5b04dcb31738bc4f17d290ea7afe8aa52531 · Zeichen 626–1673 im Abschnitt